These results suggested that CSF p-tau/Aβ increased over time, that higher GRS-AD was associated with higher CSF p-tau/Aβ, and that higher GRS-PD was associated with a faster increase in CSF p-tau/Aβ. The gene discussed is MAPT; the disease is Alzheimer disease.